Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Convertible Debt: 2016

Historic Convertible Debt for Aytu Biopharma (AYTU) over the last 1 years, with Jun 2016 value amounting to $5.2 million.

  • Aytu Biopharma's Convertible Debt was N/A to $5.2 million in Q2 2016 from the same period last year, while for Jun 2016 it was $5.2 million, marking a year-over-year change of. This contributed to the annual value of $5.2 million for FY2016, which is N/A change from last year.
  • Aytu Biopharma's Convertible Debt amounted to $5.2 million in FY2016.
  • Aytu Biopharma's Convertible Debt's 5-year high stood at $5.2 million during FY2016, with a 5-year trough of $5.2 million in FY2016.
  • Over the past 1 years, Aytu Biopharma's median Convertible Debt value was $5.2 million (recorded in 2016), while the average stood at $5.2 million.